Myofibromas are benign soft tissue neoplasms, and were previously classified as fibroblastic/myofibroblastic in origin. WHO classification of tumors of the soft tissue in 2013, reclassified them as pericytic tumors.\[[@ref1]\] They commonly occur in early infancy, and are clinically classified as solitary, multicentric without visceral involvement and multicentric with visceral involvement (generalized).\[[@ref2][@ref3]\] Though labeled as the commonest fibrous tissue tumor of infancy,\[[@ref1][@ref2]\] they are still quite rare. The term "myofibroma" is used to describe the solitary form and is the commonest form of presentation, whereas "myofibromatosis" denotes the multicentric form.\[[@ref2]\] The most common site is the head and neck regions followed by limbs and trunk.\[[@ref4]\]

Orbital myofibromas are extremely rare. Herein, we report a case of an orbital myofibroma presenting in a six-year-old child and a review of literature of pediatric orbital myofibromas.

Case Report {#sec1-2}
===========

A six-year-old male child presented with a painless progressive swelling over the lateral left lower eyelid of about six weeks' duration. There was no other associated ocular or systemic complaint.

On examination, a well-defined, firm, nodular, non-tender soft tissue mass was palpated in the lower eyelid at the lateral edge of the inferior orbital rim \[Fig. [1a](#F1){ref-type="fig"} and [b](#F1){ref-type="fig"}\]. The lower fornix and overlying skin were uninvolved. There was no globe displacement, proptosis or ocular motility restriction. Visual acuity in both eyes, and the ocular examination was normal. A detailed systemic clinical examination was unremarkable. A chest radiograph and ultrasonography of the abdomen and the pelvis were both within normal limits. On MRI of the orbits, the mass appeared hypointense on T1W images \[[Fig. 1c](#F1){ref-type="fig"}, red arrow\] and lay adjacent to the left zygomatic bone with changes suggestive of underlying bony erosion. On T2W images, it was isointense, relatively homogeneous, and well circumscribed \[[Fig. 1d](#F1){ref-type="fig"}, yellow arrow\].

![Clinical and radiological features: Well-defined, firm, non-tender soft tissue mass present on the inferolateral orbital rim (black arrow, a, b). Magnetic resonance imaging shows a well-circumscribed soft tissue mass noted to be hypointense on the T1W image (yellow arrow, c) and changes evident in the adjacent zygomatic bone (red arrow, c). The mass shows an increase in signal intensity on the T2W image (yellow arrow, d)](IJO-67-1240-g001){#F1}

An excision biopsy was performed. Intraoperatively, the mass appeared pinkish and firm. The underlying bony orbital rim was eroded \[[Fig. 2a](#F2){ref-type="fig"}, yellow arrow\]. The mass was excised from its bony attachment with a ragged base \[[Fig. 2a](#F2){ref-type="fig"}\]. Clear surgical margins were not obtained. The eroded bony base was curetted. Intra-operative squash and imprint cytology demonstrated bland appearing spindle cells suggestive of a benign spindle cell tumor.

![Intra-operative and Gross tumor morphology: intra-operatively, the portion of the zygomatic bone underlying the lesion was eroded (yellow arrow, a). On gross examination, the mass was found to be partially circumscribed (red arrow, b) with an irregular base that was abutting the underlying bone (yellow arrow, b)](IJO-67-1240-g002){#F2}

Gross examination showed a partially circumscribed mass, with a pseudocapsule surrounding three-quarters of the tumor \[[Fig. 2b](#F2){ref-type="fig"}, red arrow\]. One-quarter displayed irregular edges \[[Fig. 2b](#F2){ref-type="fig"}; yellow arrow\]. The tumor comprised predominantly of variably sized spindle cells in fascicles, and whorls intersecting at places \[Fig. [3a](#F3){ref-type="fig"} and [b](#F3){ref-type="fig"}\]. It displayed a rich vascularity \[[Fig. 3c](#F3){ref-type="fig"}\] with thin-walled slit-like branching vessels imparting a staghorn appearance \[[Fig. 3c](#F3){ref-type="fig"}, black arrow\]. Individual cells showed ill-defined cell membranes, abundant eosinophilic cytoplasm, bland, elongated, oval to round nuclei with uniform nuclear morphology. Scattered pale myxoid foci were noted around vessels. Mitotic count was 7 per 20 HPF. There was no necrosis, cytological atypia, or inflammation. A fragment of curetted bony tissue showed spicules of lamellar bone encircled by tumor cells with bland nuclear morphology \[[Fig. 3d](#F3){ref-type="fig"}, yellow asterix\].

![Morphology of Myofibroma: (a) Spindle cell tumor, cells arranged in a fascicular and whorled pattern (a: 10×). Individual cells are spindly with ill-defined cell membrane, abundant eosinophilic fibrillary cytoplasm, bland, elongated, oval, spindly to round nuclei with uniform nuclear morphology (b: 40×). Tumor is richly vascular with thin-walled slit-like to branching vessels imparting a staghorn appearance (c: 6×, black arrow marked). Tumor cells with bland nuclear morphology are seen surrounding fragments of cancellous bone (d, asterix marked, 10×; Haematoxylin and Eosin stain)](IJO-67-1240-g003){#F3}

Tumor cells showed strong cytoplasmic expression of vimentin \[[Fig. 4a](#F4){ref-type="fig"}\], smooth muscle actin \[SMA, [Fig. 4b](#F4){ref-type="fig"}\], and muscle-specific antigen (MSA), and were negative for desmin, ALK-1, and S-100. CD34 decorated the vessels \[[Fig. 4c](#F4){ref-type="fig"}\], but not the tumor cells. Ki-67 showed a labeling index of 1--2% \[[Fig. 4d](#F4){ref-type="fig"}\]. The morphological and immunohistochemical features were consistent with myofibroma. A systemic evaluation was unremarkable, and a diagnosis of solitary orbital myofibroma was made.

![Immunohistochemical staining of Myofibroma: tumor cells strongly express Vimentin (a) and SMA (b); CD 34 decorated the vessel walls (c), but was not expressed in tumor cells. Ki -67 shows 1--2% (d), yellow arrow marked) of proliferative activity](IJO-67-1240-g004){#F4}

Discussion {#sec1-3}
==========

Myofibroma has a diverse clinical presentation varying from aggressive multicentric to benign localized forms. It is rarely self-regressing and was historically identified by several names, such as infantile myofibromatosis (IM), congenital-infantile hemangiopericytoma (CIH), and congenital-infantile fibrosarcoma (CIF). A systematic review of similar lesions had led to the introduction of the term juvenile fibromatoses. The disease was described to have solitary, multiple, and generalized forms.\[[@ref5]\] Subsequently, the skin tumors and tumors of soft tissue and bone working groups advocated usage of the terms "myofibroma", "solitary myofibroma", or "solitary cutaneous myofibroma" to denote solitary lesions of IM and the term "myofibromatosis" for the multicentric forms.\[[@ref6]\]

Solitary and multicentric forms can involve the skin, subcutaneous tissue, muscle, and bone. In solitary myofibroma, visceral involvement is very rare.

Multicentric forms with visceral involvement can involve heart wall, pulmonary parenchyma, pleura, thyroid gland, adrenal gland, kidney, pancreas, gastrointestinal tract, mesentery, liver, and rarely the central nervous system. Multicentric forms may demonstrate familial inheritance, present earlier in life, and the number of lesions may widely vary (even upto 100). Mortality due to mass effect and visceral involvement, recurrence, and spontaneous regression on observation has been reported in multicentric forms.

Orbital myofibromas are a group of rare, benign, but locally infiltrative tumors of infants with only a few case reports described in children.\[[@ref3]\] Kodsi *et al*. reported only a single case of myofibroma in a review of 340 orbital tumors in children accumulated over a period of sixty years.\[[@ref5]\]

A review of English literature revealed 25 cases of orbital myofibroma \[[Table 1](#T1){ref-type="table"}\] of which one case had limited information and was excluded from tabulation. There was male preponderance with a M:F ratio of 2.12:1.00. One-third of the cases were congenital, with 60% presenting at the age of less than two years. In total, 72% of the cases had involvement on the left side.

###### 

Review of cases of pediatric orbital myofibroma

  Author, Yr.                             Age (m); Sex        Presenting complaints                       Duration of complaints (m)                  Site of involvement/Laterality                             Other sites                                                                       CT/MRI                                                                                                                                         Tt                             FU (yrs)    Outcome, recurrence
  --------------------------------------- ------------------- ------------------------------------------- ------------------------------------------- ---------------------------------------------------------- --------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------ ----------- ---------------------
  Wiswell TE *et al*., 1985               neonate; F          Mass                                        Birth                                       LE Lower eyelid/UL                                         Upper lip, nose on left side                                                      NM                                                                                                                                             NM                             NM          NM
  Waeltermann JM *et al*., 1988           infant; M           Proptosis                                   Birth                                       LE Orbit/UL                                                Intracranial extension                                                            Orbital mass with intracranial extension                                                                                                       Incision and close follow up   NM          NM
  Nasr AM *et al*., 1986                  5m; M               Proptosis                                   Birth                                       RE Superolateral orbit/UL                                  Cranial cavity, Soft tissue-ear, axilla, buttock                                  Well defined homogeneous intraorbital mass with bone erosion                                                                                   Excision                       0.5         Good, Nil
  Stautz CC *et al*., 1991                neonate; M          Proptosis                                   Birth                                       LE Orbit/UL                                                Cranium                                                                           Ill defined homogeneous hyperdense mass in orbit with SOF dilatation and intracranial extension                                                Incision and close follow up   4           Stable, Nil
  Campbell RJ *et al*., 1991              30m; M              Ptosis and inferior displacement of globe   6                                           RE Superolateral orbit/UL                                  NM                                                                                Well defined homogeneous enhancing mass, sclerosis and bone remodelling                                                                        Excision                       NM          Good, Nil
  Linder JS *et al*., 1996                \<1m; M             Lower eyelid and medial canthal mass        Birth                                       LE Lower eyelid and medial canthus/UL                      Not involved                                                                      NM                                                                                                                                             Subtotal resection             1.5         Stable, Nil
  Duffy M T *et al*., 1997                48m; F              Lower eyelid mass                           \<1                                         RE Inferolateral orbit/UL                                  Not involved                                                                      Well defined homogeneous enhancing mass, loss of bone and surrounding hyperostosis                                                             Excision                       0.5         Good, Nil
  Shields CL *et al*., 1998               3m; F               Proptosis                                   2                                           LE Sphenoid bone/UL                                        Not involved                                                                      Well defined intraosseous mass with lytic lesion                                                                                               Subtotal resection             NM          Good, NM
  Tokano H *et al*., 2001                 120m; M             Not mentioned                               NM                                          LE Lateral orbital floor/UL                                NM                                                                                Orbital mass with bony destruction                                                                                                             Incision                       0.5         Good, Nil
  Westfall AC *et al*., 2003 (2 cases)    neonate; M          Lower eyelid mass                           Birth                                       LE Lower eyelid/UL                                         Not involved                                                                      Heterogeneous mass with variable soft tissue densities and small areas of calcification. There was no extension of the tumour into the orbit   Excision                       7           Good, Nil
                                          72m; M              Upper eyelid mass                           1                                           LE Superonasal orbit/UL                                    Not involved                                                                      Homogeneous well defined isodense mass in superonasal orbit, no bone changes                                                                   Incision                       1           Stable, Nil
  Larsen AC *et al*., 2003                12m; F              Proptosis and swelling of eyelid            \<1                                         LE Superolateral orbit/UL                                  Not involved                                                                      Well defined homogeneous                                                                                                                       Excision                       NM          Good, Nil
  Cruz AA *et al*., 2004                  6m; M               Not mentioned                               5                                           LE Superolateral orbit/UL                                  Head and neck                                                                     Well defined lesion with erosion of superolateral bony rim                                                                                     Excision                       0.5         Good, Nil
  Nam DH *et al*., 2005                   36m; M              Lower eyelid mass                           2                                           LE Inferolateral orbit/UL                                  Not involved                                                                      Well defined homogeneous mass with bone erosion and hyperostosis                                                                               Excision                       1.3         Good, Nil
  Koujok *et al*., 2005                   \<1m; M             Not mentioned                               NM                                          LE Infraorbital region/UL                                  Lumbosacral plexus neuropathy, left psoas, left iliac bone, left forearm          NM                                                                                                                                             Incision                       NM          NM
  Persaud TO *et al*., 2006               29m; M              Proptosis                                   \<1                                         LE Superior orbit- Greater wing of sphenoid/UL             Middle cranial fossa, adherent to dura                                            Well defined homogeneous mass with bone erosion and hyperostosis                                                                               Excision                       NM          Good, Nil
  Rodrigues EB *et al*., 2006 (4 cases)   72m; M              Lower eyelid fullness                       2                                           RE Orbital floor/UL                                        Not involved                                                                      Well defined homogeneous Intraosseous mass with thinned bony margins                                                                           Excision + bone removal        3           Good, Nil
  11m; M                                  Proptosis           9                                           LE Superotemporal intraosseous mass/UL      Not involved                                               Well defined superotemporal intraosseous mass with bone destruction               Excision                                                                                                                                       0.5                            Good, Nil   
  7m; F                                   Lower eyelid mass   NM                                          RE Orbit, maxillary and zygomatic bone/UL   Not involved                                               Well defined mass with bone infiltration and erosion                              Excision                                                                                                                                       3                              Good, Nil   
  3m; F                                   Proptosis           2                                           LE Orbit, maxillary and zygomatic bone/UL   Not involved                                               Left sphenoid bone with osteolytic lesion                                         Excision                                                                                                                                       3                              Good, Nil   
  Galassi E *et al*., 2008                17m; F              Strabismus and ptosis                       1                                           RE Eyelid/UL                                               Ethmoid sinus, maxillary sinus, anterior skull base with intracranial extension   Inhomogeneously enhancing mass with partial calcification                                                                                      Excision                       0.5         Good, Nil
  Mynatt CJ *et al*., 2011                36m; M              Mass                                        3                                           LE Intraosseous mass of superolateral margin of orbit/UL   Not involved                                                                      Osteolytic expansile intraosseous lesion                                                                                                       Bone curettage                 1           Stable, Nil
  Bloom RI *et al*., 2013                 neonate; F          Proptosis                                   Birth                                       RE Retrobulbar mass/UL                                     Not involved                                                                      Retrobulbar mass with mass effect on frontal bone                                                                                              Debulking                      2           Stable, Nil
  Bahram Eshraghi *et al*., 2017          60m; M              mass                                        1.5                                         LE Superolateral orbit/UL                                  Not involved                                                                      Well defined isodense homogeneous mass with bone erosion                                                                                       Excision                       1           Good, Nil
  Present case, 2018                      72m; M              Lower eyelid mass                           1.5                                         LE Inferolateral orbit-zygomatic bone/UL                   Not involved                                                                      Well defined homogeneous mass with bone erosion                                                                                                Excision                       0.5         Good, Nil

Yr- year; m-month; F/M- female/male; LE- left eye; RE- right eye; UL- unilateral; Tt- treatment; FU- follow up; NM- not mentioned

The commonest presentation was a gradually progressive unilateral (100%) orbital mass with soft tissue and bony involvement \[47.8%, [Table 1](#T1){ref-type="table"}\].\[[@ref3][@ref7][@ref8][@ref9][@ref10][@ref11][@ref12][@ref13][@ref14][@ref15][@ref16][@ref17][@ref18][@ref19][@ref20][@ref21][@ref22][@ref23][@ref24][@ref25]\] The presence of bony erosion can make the clinicoradiological diagnosis of myofibroma more challenging. None of the orbital myofibromas demonstrated recurrence at a mean follow up of 20 months (range 6--84 months).

The major differential diagnoses include fibrous histiocytoma, nodular fasciitis, fibromatosis, infantile fibrosarcoma, solitary fibrous tumor, neurofibroma, and hemangiopericytoma.\[[@ref3][@ref9]\] Rarely, malignant lesions like Ewings sarcoma family of tumors and rhabdomyosarcoma may need exclusion. Fibrous dysplasia and non-ossifying fibroma may also need exclusion in cases with predominant osseous involvement. In recent years, studies have revealed consistent pathological findings with a typical fascicular pattern of a rich vascular spindle cell tumor with occasional staghorn-like channels. The centre of the lesion might display more cellularity. Review of published literature showed that all the cases in which IHC was performed (15/25) expressed SMA \[[Table 1](#T1){ref-type="table"}\]. These tumors were also found to have strong expression of vimentin, muscle-specific actin, and were negative for desmin, CD34, ALK-1 and S-100.

Though recurrences in myofibroma are extremely rare in spite of positive surgical margins,\[[@ref4]\] complete surgical excision should still be the goal.\[[@ref12]\] Conservative debulking followed by close observation can be considered in cases with difficulty in total excision. There is no conclusive evidence supporting the benefit of adjunctive radiotherapy or chemotherapy in solitary orbital myofibromas.\[[@ref11]\] Therefore, a regular follow-up is probably the best-recommended policy.

Conclusion {#sec1-4}
==========

In conclusion, myofibroma can rarely present in children as a progressive orbital mass with bony erosions simulating a malignant tumor. A conservative/complete excision may cure the tumor with a very low rate of recurrence. A definitive diagnosis and differentiation from other tumors are dependent upon the microscopic findings and immunohistochemistry.
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